Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 7/20 | 0.52 |
| ▸ | RAB9A | P51151 | 7/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | VRK1 | Q99986 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8990150 | 0.98 | DYRK1A (0.56) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| SCHEMBL31452850 | 0.89 | DYRK1A (0.49) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| SCHEMBL22130152 | 0.84 | DYRK1A (0.70) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| Trifluoroacetic Acid SCHEMBL5028767 | 0.83 | NPC1 (0.54) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| SCHEMBL27835644 | 0.83 | NPC1 (0.50) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| SCHEMBL29363971 | 0.83 | ALDH1A1 (0.50) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| SCHEMBL115598 | 0.83 | ALDH1A1 (0.50) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| Hydrochloric Acid SCHEMBL16861131 | 0.81 | ALDH1A1 (0.48) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| Methane SCHEMBL11806579 | 0.81 | ALDH1A1 (0.48) | DYRK1ANPC1RAB9AKDM4EHKDC1 | |
| SCHEMBL15688976 | 0.79 | SMN1; SMN2 (0.43) | DYRK1ANPC1RAB9AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720318-A1 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GLYOXAL | Solugen, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | SOLUGEN, INC. (US) | 2025-06-05 | — | — | US | claimed |
| CN-119968007-A | Perovskite solar cell based on ion-induced interface electric field and preparation method thereof | 嘉庚创新实验室 | 2025-05-09 | — | — | CN | claimed |
| WO-2025076549-A1 | SMALL MOLECULE ACTIVATORS | SOLUGEN, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| CN-119241449-A | Piperazine derivative and preparation method and application thereof | 重庆市畜牧科学院 | 2025-01-03 | — | — | CN | claimed |
| CN-119080714-A | Azobenzenesulfonate compound, preparation method and application thereof, and preparation method of radioactive probe | 四川大学 | 2024-12-06 | — | — | CN | claimed |
| WO-2024249896-A1 | METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GLYOXAL | SOLUGEN, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| CN-115354369-B | Ultra-deep hole TSV electroplating solution for MEMS device packaging | 珠海市创智成功科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-115449860-B | Nickel-gold electroplating liquid for ceramic substrate and electroplating process thereof | 深圳创智芯联科技股份有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-118290352-A | Azo compound, preparation method and application thereof, and medicinal composition | 四川大学 | 2024-07-05 | — | — | CN | claimed |
| US-6372077-B1 | COATING A FIBER WITH A POWDER ENCAPSULANT MATERIAL IN A HIGHLY DISPERSED COLLOIDAL SUSPENSION SUCH THAT THE ENCAPSULATED PARTICLES REMAIN INDEPENDENT AND DISCRETE UPON SEPARATION | TECLE BERHAN (US) | 2002-04-16 | — | — | US | claimed |
| EP-0917501-B1 | METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES | TECLE BERHAN (US) | 2001-09-19 | — | — | EP | claimed |
| EP-1132127-A2 | Method for isolating ultrafine and fine particles and resulting particles | Tecle, Berhan (US) | 2001-09-12 | — | — | EP | claimed |
| US-6190731-B1 | FORMING A HIGHLY DISPERSED COLLOIDAL SUSPENSION OF PARTICLES, ADDING TO THE SUSPENSION AN ENCAPSULANT MATERIAL TO ENCAPSULATE INDIVIDUAL PARTICLES, AND ISOLATING FROM SAID SUSPENSION INDEPENDENT ENCAPSULATED PARTICLES | Tecle, Berhan | 2001-02-20 | — | — | US | claimed |
| US-5922403-A | ADDING ENCAPSULANT TO HIGHLY DISPERSED COLLOIDAL SUSPENSION OF SOLID PARTICLES TO ENCAPSULATE INDIVIDUAL PARTICLES; AGGLOMERATING; ISOLATING ENCAPSULATED PARTICLES BY SEPARATION FROM SOLVENT LAYER | TECLE, BERHAN | 1999-07-13 | — | — | US | claimed |
| EP-0917501-A1 | METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES | Tecle, Berhan (US) | 1999-05-26 | — | — | EP | claimed |
| WO-1997033713-A1 | METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES | TECLE BERHAN (US) | 1997-09-18 | — | — | WO | claimed |
| EP-0396584-B1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES | MICROBIOLOGICAL RES AUTHORITY (GB) | 1995-01-25 | — | — | EP | claimed |
| EP-0396584-A1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES. | HEALTH LAB SERVICE BOARD (GB) | 1990-11-14 | — | — | EP | claimed |
| WO-1989005356-A1 | ASSAY OF SALICYLATES OR REDUCED PYRIDINE NUCLEOTIDES | THE PUBLIC HEALTH LABORATORY SERVICE BOARD (GB) | 1989-06-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | G6PD, SOD1, UGDH | DYRK1A 2424/4885NPC1 4104/4885RAB9A 3888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.